Quick Answer
TriSalus Life Sciences, Inc. reported Earnings Per Share Diluted of $1.84 (loss) per share for the year ending 2025.
- TriSalus Life Sciences, Inc. showed a decrease of -40.5% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from TriSalus Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $25.95 (loss) per share | Q1 2023: $0.57 (loss) per share | Q2 2023: $35.84 (loss) per share | Q3 2023: $0.14 (loss) per share | Q1 2024: $0.60 (loss) per share | Q2 2024: $0.21 (loss) per share | Q3 2024: $0.12 (loss) per share | Q1 2025: $0.39 (loss) per share | Q2 2025: $0.27 (loss) per share | Q3 2025: $0.96 (loss) per share.
- Over the full 4 years of available data (2022 to 2025), TriSalus Life Sciences, Inc.'s Earnings Per Share Diluted has grown by 98.9%.
- Historical annual values: Fiscal year 2025: $1.84 (loss) per share | Fiscal year 2024: $1.31 (loss) per share | Fiscal year 2023: $6.77 (loss) per share | Fiscal year 2022: $161.55 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: